CytRx Corp (CYTR.OQ)
CYTR.OQ on NASDAQ Stock Exchange Capital Market
0.47USD
14 Dec 2018
0.47USD
14 Dec 2018
Change (% chg)
$-0.03 (-5.39%)
$-0.03 (-5.39%)
Prev Close
$0.50
$0.50
Open
$0.50
$0.50
Day's High
$0.50
$0.50
Day's Low
$0.47
$0.47
Volume
9,813
9,813
Avg. Vol
20,432
20,432
52-wk High
$2.35
$2.35
52-wk Low
$0.47
$0.47
About
CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue... (more)
Overall
| Beta: | 2.34 |
| Market Cap(Mil.): | $69.25 |
| Shares Outstanding(Mil.): | 165.83 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CYTR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.71 | 34.39 |
| EPS (TTM): | -0.41 | -- | -- |
| ROI: | -112.76 | 9.01 | 14.96 |
| ROE: | -214.05 | 10.15 | 16.52 |
Estimates